GEOWARD92 LTD
Company number 13001144 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
GEOWARD92 LTD - Analysis Report
Company Number: 13001144
Analysis Date: 2025-07-20 14:19 UTC
Credit Opinion: DECLINE. Geoward92 Ltd demonstrates persistent net current liabilities and negative net assets over multiple years, indicating a weak financial position and insufficient resources to meet short-term obligations. The company operates at a micro scale with minimal capital and no equity buffer, which raises significant credit risk. The lack of profitability and growing net liabilities suggest limited capacity to service debt or honor commercial commitments reliably.
Financial Strength: The balance sheet reveals a deteriorating financial condition with net liabilities increasing from £-8,787 in 2020 to £-16,262 in 2023. Current liabilities exceed current assets by a substantial margin, reflecting poor working capital management and potential liquidity stress. The absence of fixed assets and minimal share capital (£1.00) provide no cushion. Negative shareholders’ funds further affirm the company’s insolvency risk and weak financial resilience.
Cash Flow Assessment: Current assets are low and primarily consist of cash or receivables totaling £15,313 as of 2023 year-end, but current liabilities stand nearly double at £31,575. This imbalance indicates ongoing cash flow constraints, with insufficient liquid resources to cover immediate debts. The company’s negative net current assets position suggests it may struggle to maintain operational liquidity without external funding or capital injection.
Monitoring Points:
- Watch for any improvements in net current assets and net liabilities in forthcoming accounts.
- Monitor cash flow statements if available for operational cash generation trends.
- Track creditor payment terms and any defaults or delayed payments.
- Observe any changes in capital structure or new equity injections.
- Review director’s reports or disclosures for business turnaround plans or restructuring.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.